Jingfeng Bi - Concepedia

Author

Jingfeng Bi

Chinese PLA General Hospital ORCID

Also Known As

Bi J, Bi Jingfeng, Bin‐xia Chang, J. Bi, Jing-Feng Bi, Jing-feng Bi, Jingfeng Bi, Jing‐Feng Bi, Ying Wang

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Chinese PLA General Hospital Capital Medical University 302 Military Hospital of China Fuyang Second People's Hospital Chinese People's Liberation Army

About

Jingfeng Bi is an author at Chinese PLA General Hospital specializing in medicine, epidemiology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	155
2	Epidemiology	2	2	124
3	Hepatology	2	2	69
4	Health Sciences	1	1	38
5	Public Health	1	1	86

Jingfeng Bi

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score Dong Ji, Dawei Zhang, Jing Xu, Clinical Infectious Diseases	2020	712
Clinical Features of Patients With Ebola Virus Disease in Sierra Leone Enqiang Qin, Jingfeng Bi, Min Zhao, Clinical Infectious Diseases	2015	92
Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China Lijun Sun, Lijun Shen, Junfen Fan, Journal of Medical Virology Coronavirus Disease 2019Virus EpidemiologyViral DiagnosticsEmerging Infectious DiseasesCovid-19 Pandemic	2020	86
Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B Dong Ji, Yan Chen, Jingfeng Bi, Journal of Hepatology	2022	58
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Guanghua Rong, Yong‐Ping Chen, Zujiang Yu, The Journal of Infectious Diseases	2020	41
Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis Yang‐xin Xie, Bo Tu, Zhe Xu, Scientific Reports Liver CirrhosisAntimicrobial ChemotherapyAntibiotic ResistanceDrug ResistanceSepsis	2017	38
Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study Chunyan Wang, Ya Deng, Ping Li, Hepatology	2021	36
Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis Qiuxia Ren, Xingang Li, Jinsong Mu, Journal of Pharmaceutical Sciences Pharmacokinetic ModelingHepatologyPharmacological StudyPharmacologyPharmacotherapy	2019	31
Corticosteroid plus glycyrrhizin therapy for chronic drug‐ or herb‐induced liver injury achieves biochemical and histological improvements: a randomised open‐label trial Jiabo Wang, Ang Huang, Yijin Wang, Alimentary Pharmacology & Therapeutics	2022	28
Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection Yang‐xin Xie, Bo Tu, Xin Zhang, Oncotarget	2017	17

Page 1